Cardiac Dimensions® Announces Presentation of Two-Year Efficacy Data from TITAN Clinical Trial
November 7, 2011
Cardiac Dimensions® Names Omari V. Bouknight Vice President of Sales and Marketing
October 13, 2011
Cardiac Dimensions® Announces First Patient Treated In TITAN II Clinical Trial
October 11, 2011
Cardiac Dimensions® Receives CE Mark Approval For Enhanced CARILLON® Mitral Contour System™
September 29, 2011
Cardiac Dimensions® Announces 12-Month Follow-Up Data of TITAN™ Trial
August 18, 2010
Cardiac Dimensions® Inc. Receives 2009 Best of Kirkland Award
July 15, 2009
SCAI Highlights Cardiac Dimensions® Inc. AMADEUS™
May 04, 2009
Cardiac Dimensions® Inc. Receives CE Mark for CARILLON™
February 02, 2009
Cardiac Dimensions® Inc. Cardiac Dimensions® Inc. Announces New VP
November 18, 2008
Cardiac Dimensions® Inc. Receives ISO 13485:2003 Certification
October 14, 2008
Cardiac Dimensions® Inc. announces Key Personnel Changes
September 19, 2008
Cardiac Dimensions® Inc. Announces Closing of $35.5 Million Round of Financing
December 18, 2007
Steven Goldberg, M.D. joins Cardiac Dimensions® as Chief Clinical Officer
April 19, 2006
Cardiac Dimensions® Inc. Announces First Implant of CARILLON™ Mitral Contour System
July 21, 2005
Cardiac Dimensions® Closes $15 Million Series C
March 17, 2004
Cardiac Dimensions® Raises $12M
June 25, 2002